Driving Sustainable GLP-1 Outcomes & ROI for Employers

Most employer GLP-1 coverage strategies are built around one question: what does the medication cost? But cost is only one input in the ROI equation. Real-world data shows that more than 50% of GLP-1 users discontinue within 12 weeks, and nearly all patients on GLP-1s for weight loss regain the weight within two years without structured support. The harder question isn’t whether to cover GLP-1s, it’s how to make that coverage sustainable.

In this expert panel, Goodpath’s Medical Director, Dr. Nishu Uppal, Director of Mental Health Dr. James Lyda, and Pharmacy & Benefits Advisor, Aaron Wurst break down the clinical, behavioral, and economic factors that determine whether a GLP-1 coverage strategy delivers lasting ROI, or becomes an expensive cycle of starts and stops.